CNMD Financial Facts
Research and development expense: 8.35MProvision for income taxes: 2.65M
See Full Income Statement
Accumulated other comprehensive loss: -51.82M
Goodwill: 398.38M
See Full Balance Sheet
CONMED Corporation (CNMD) Earnings
|
Expand Research on CNMD
| Next EPS Date | 7/24/24 *Est. | EPS Growth Rate | +19.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +3.9% | Revenue Growth Rate | +5.7% *Last Qtr. |
| Average % Move 1-Wk after EPS | -5.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/24/24 | Q124 | $0.79 | $0.74 | +$0.05 | $312.3M | $306.73M | = |  | | Details | |
| 1/31/24 | Q423 | $1.06 | $1.11 | -$0.05 | $327M | $332.22M | = | | | Details | |
| 10/25/23 | Q323 | $0.90 | $0.83 | +$0.07 | $304.6M | $300.91M | = | | | Details | |
| 7/26/23 | Q223 | $0.83 | $0.79 | +$0.04 | $317.7M | $306.06M | = | | | Details | |
| 4/26/23 | Q123 | $0.66 | $0.60 | +$0.06 | $295.5M | $266.67M | = | | | Details | |
| 2/2/23 | Q422 | $0.42 | $0.90 | -$0.48 | $250.9M | $302.51M | = | | | Details | |
| 10/26/22 | Q322 | $0.77 | $0.75 | +$0.02 | $275.09M | $280.89M | = | | | Details | |
| 7/27/22 |  |
Q222 | $0.76 | $0.75 | +$0.01 | $277.2M | $274.25M | = | | | Details |
